By Daniel Webster, dWeb.News Publisher
PISCATAWAY, N.J.–(BUSINESS WIRE)–IBX, a global leader in biobanking, bioprocessing and analytics, has acquired UK based biospecimen storage specialists Roylance Pharma.
We are thrilled to welcome the Roylance Pharma staff into the IBX family. Robin Grimwood, Infinity BiologiX CEO, stated that combining these two amazing organisations will strengthen our support for our clients while accelerating our already impressive international growth.
The team and capabilities of Roylance Pharma complement the IBX. Grimwood stated that IBX’s strategy and mission is being reinforced by the establishment of a UK-based biobanking and processing hub. This will also strengthen our offer to clients and ensure we continue to provide world-class biomaterial services.
Benedict Roylance is the Co-Founder of Roylance Pharma. He said that “Joining Roylance Pharma with IBX will be a natural fit. Both groups of clients as well as teams will benefit from it.” We can expand our reach internationally and share the wealth of expertise within both companies so we can drive greater growth and support our clients’ research projects.”
Marieanne Miller said that “We’re thrilled to bring the Roylance Pharma team expertise into IBX. We have decades of experience in MHRA licensed stability storage, biostorage and on-site servicing. This acquisition will allow us to offer clients the same high level attention across a wider range services.
IBX’s rapid expansion means that we are well equipped to provide quality control and control across all regions. I’m proud to have laid another piece of the foundation as we celebrate our first year as IBX, previously known as RUCDR. Grimwood said that IBX is looking forward to expanding its footprint to continue to show our commitment to clients’ success.
About Infinity biologiX (IBX). IBX supports academia, government and industry with a disruptive next-generation central laboratory. IBX offers global sample collection, processing and storage. It also provides technical and scientific support in the clinical and research arenas. IBX is a world leader in biomaterials and provides support for the development of diagnostics and therapeutics as well as research in genomics, precision and regenerative medicine. IBX was previously known as RUCDRInfinite Biologics, before being spun off by Rutgers University – New Brunswick in August 2020..
Please visit http://www.ibx.bio for more information.
About Roylance Pharma. Roylance Pharma is a UK-based specialist in biobanking, stability storage of pharmaceutical and biologic samples. They have over 50years of experience specifically in sample storage. The process has been designed from scratch with the latest facilities, validation, SOPs, and quality systems. Roylance Storage places great emphasis on customer service and client relationships built on trust, honesty, and integrity.
For more information please visit http://www.roylancepharma.com.
More dWeb.News Business News at https://dweb.news/news-sections/business-news/